The role of D1-D2 receptor hetero-dimerization in the mechanism of action of clozapine

被引:34
作者
Faron-Gorecka, Agata [1 ]
Gorecki, Andrzej [2 ]
Kusmider, Maciej [1 ]
Wasylewski, Zygmunt [2 ]
Dziedzicka-Wasylewska, Marta [1 ,2 ]
机构
[1] Polish Acad Sci, Dept Pharmacol, Inst Pharmacol, PL-31343 Krakow, Poland
[2] Jagiellonian Univ, Dept Phys Biochem, Fac Biochem Biophys & Biotechnol, Krakow, Poland
关键词
clozapine; dopamine receptors; receptor oligomerization; schizophrenia; fluorescence rezonans energy transfer (FRET); HEK; 293;
D O I
10.1016/j.euroneuro.2008.05.001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Clozapine is effective although stilt not perfect drug used to treat schizophrenia. The precise mechanism of its action is not known. Here we show that there are two binding sites for clozapine at the dopamine D-1 and D-2 receptors, and the affinity of D1R strongly depended on whether the receptor was present alone or together with D2R (or its genetic variant D-2(Ser311Cys)) in the cell membrane, pointing to the rote of receptor hetero-dimerization in the observed phenomenon. The use of fluorescence resonance energy transfer (FRET) technology, observed via fluorescence lifetime microscopy of the single cell, indicated that low concentration of clozapine (10(-9) M), sufficient to saturate the high affinity site, uncoupled the D1R-D2R hetero-dimers. Therefore it has been concluded that clozapine might antagonize the effect of concomitant stimulation of both dopamine receptors, which has been shown previously to enhance the formation of hetero-dimers and to stimulate the calcium signaling pathway. (C) 2008 Elsevier B.V. and ECNP. All rights reserved.
引用
收藏
页码:682 / 691
页数:10
相关论文
共 54 条
  • [1] Clozapine:: Dopamine D1 receptor agonism in the prefrontal cortex as the code to decipher a rosetta stone of antipsychotic drugs
    Ahlenius, S
    [J]. PHARMACOLOGY & TOXICOLOGY, 1999, 84 (05): : 193 - 196
  • [2] Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons
    Aizman, O
    Brismar, H
    Uhlén, P
    Zettergren, E
    Levey, AI
    Forssberg, H
    Greengard, P
    Aperia, A
    [J]. NATURE NEUROSCIENCE, 2000, 3 (03) : 226 - 230
  • [3] Inverse agonist properties of atypical antipsychotic drugs\
    Akam, E
    Strange, PG
    [J]. BIOCHEMICAL PHARMACOLOGY, 2004, 67 (11) : 2039 - 2045
  • [4] Abnormalities in the dopamine system in schizophrenia may lie in altered levels of dopamine receptor-interacting proteins
    Bai, J
    He, F
    Novikova, SI
    Undie, AS
    Dracheva, S
    Haroutunian, V
    Lidow, MS
    [J]. BIOLOGICAL PSYCHIATRY, 2004, 56 (06) : 427 - 440
  • [5] BALDESSARINI RJ, 1991, NEW ENGL J MED, V324, P746
  • [6] Doparnine receptor-interacting proteins:: the Ca2+ connection in dopamine signaling
    Bergson, C
    Levenson, R
    Goldman-Rakic, PS
    Lidow, MS
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (09) : 486 - 492
  • [7] Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method
    Breier, A
    Su, TP
    Saunders, R
    Carson, RE
    Kolachana, BS
    de Bartolomeis, A
    Weinberger, DR
    Weisenfeld, N
    Malhotra, AK
    Eckelman, WC
    Pickar, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) : 2569 - 2574
  • [8] NEW INSIGHTS INTO THE BIOLOGY OF SCHIZOPHRENIA THROUGH THE MECHANISM OF ACTION OF CLOZAPINE
    BRUNELLO, N
    MASOTTO, C
    STEARDO, L
    MARKSTEIN, R
    RACAGNI, G
    [J]. NEUROPSYCHOPHARMACOLOGY, 1995, 13 (03) : 177 - 213
  • [9] Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors:: Identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist
    Burstein, ES
    Ma, J
    Wong, S
    Gao, Y
    Pham, E
    Knapp, AE
    Nash, NR
    Olsson, R
    Davis, RE
    Hacksell, U
    Weiner, DM
    Brann, MR
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (03) : 1278 - 1287
  • [10] Inverse agonist properties of dopaminergic antagonists at the D1A dopamine receptor:: Uncoupling of the D1A dopamine receptor from Gs protein
    Cai, GP
    Gurdal, H
    Smith, C
    Wang, HY
    Friedman, E
    [J]. MOLECULAR PHARMACOLOGY, 1999, 56 (05) : 989 - 996